factual

What is 'cobranding' in the context of a Dermani Medspa franchise?

Dermani_Medspa Franchise · 2025 FDD

Answer from 2025 FDD Document

  • 9.1.3. We may, from time to time, incorporate into the System programs, products or services which we either develop or otherwise obtain rights to, which are offered and sold under names, trademarks and/or service marks other than the Marks and which your Franchised Business, along with other dermani MEDSPA® franchised businesses, will be required to offer and sell. This activity, referred to as "cobranding", may involve changes to the Marks and may require you to make modifications to your Premises and the furniture, fixtures, equipment, signs and trade dress of your Franchised Business. If you receive written notice that we are instituting a cobranding program, you agree promptly to implement that program at your Franchised Business at the earliest commercially reasonable time and to execute any and all instruments required to do so. Under no circumstance will any cobranding program increase your Royalty Fees, System Marketing Fee or local marketing expenditure obligations under this Agreement.

Source: Item 23 — RECEIPTS (FDD pages 66–311)

What This Means (2025 FDD)

According to the 2025 Dermani Medspa Franchise Disclosure Document, cobranding refers to the incorporation of programs, products, or services into the Dermani Medspa system that are offered and sold under names, trademarks, or service marks other than the Dermani Medspa marks. This means that Dermani Medspa may introduce new offerings that are branded differently from the core Dermani Medspa brand but are still part of the services franchisees are required to provide.

This activity may involve changes to the existing Dermani Medspa marks and could necessitate modifications to the franchisee's premises, including furniture, fixtures, equipment, signs, and trade dress. In essence, franchisees might need to update the look and feel of their medspa to align with the new cobranded offerings. Dermani Medspa is obligated to provide written notice to franchisees when instituting a cobranding program, and franchisees are expected to promptly implement the program at their location at the earliest commercially reasonable time, including executing any required instruments.

Importantly, the FDD states that no cobranding program will increase the franchisee's Royalty Fees, System Marketing Fee, or local marketing expenditure obligations under the Franchise Agreement. This provides some financial reassurance to franchisees, as they won't be burdened with additional fees directly resulting from the implementation of cobranding initiatives. However, franchisees should still be prepared for potential costs associated with modifying their premises or purchasing new equipment to accommodate the cobranded offerings. Franchisees should clarify with Dermani Medspa what financial support or resources will be provided during the implementation of any cobranding programs.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.